MinION has already been successfully used by our group to detect mutations of the TP53 and ABL1 genes in chronic lymphocytic leukemia (CLL) and in chronic myeloid leukemia (CML) patients, respectively [8,9,10]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.